Therma Bright Teams Up with Quantify Medical as Exclusive U.S. Distributor: A Game-Changing Partnership for Health and Wellness – Press Release Date: August 22, 2024

Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900 Toronto, Ontario–(Newsfile Corp. – October 10, 2024) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) (“Therma” or the “Company”), a developer and investment partner in a wide range…

Read More

“Get Ready for a Crypto Turnaround: Ethereum, Solana, and XRP Showing Signs of Reversal, Says Analyst Jason Pizzino”

Cryptocurrency analyst Jason Pizzino’s Bold Predictions and What They Mean for You Introduction Jason Pizzino, the popular cryptocurrency analyst and trader, has once again made waves in the market with his latest predictions. With over 348,000 YouTube subscribers eagerly waiting for his insights, Pizzino believes that three top altcoins are primed for bullish reversals following…

Read More

Maximizing Returns: Understanding the Impact of Share Buybacks on Company Performance

Transaction in Own Shares 05 November, 2024 Shell plc (the ‘Company’) announces that on 05 November 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase 05/11/2024 Number of Shares purchased 1,078,300 Highest price paid £26.1000 Lowest price paid £25.8450 Volume weighted average…

Read More

Coherus Unveils Exciting Toripalimab Findings at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on M… Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 status when administered in combination with chemotherapy During the 2023 AACR-NCI-EORTC International Conference, Coherus Biosciences presented groundbreaking data on the efficacy of Toripalimab in activating…

Read More